Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets

[1]  Sébastien Dupont,et al.  Optimized tableting for extremely oxygen-sensitive probiotics using direct compression. , 2018, International journal of pharmaceutics.

[2]  Aline C. Freitas,et al.  Quantification, isolation and characterization of Bifidobacterium from the vaginal microbiomes of reproductive aged women. , 2017, Anaerobe.

[3]  Varsha Gupta,et al.  Recurrent urinary tract infections in women: How promising is the use of probiotics? , 2017, Indian journal of medical microbiology.

[4]  L. Siroli,et al.  Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products , 2017, Front. Microbiol..

[5]  Arik Dahan,et al.  Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms , 2017, Medicinal research reviews.

[6]  B. Vitali,et al.  Management of Disease and Disorders by Prebiotics and Probiotic Therapy: Probiotics in Bacterial Vaginosis , 2017 .

[7]  M. Labra,et al.  Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study , 2017, Archives of Gynecology and Obstetrics.

[8]  M. Ayub,et al.  Probiotics production and alternative encapsulation methodologies to improve their viabilities under adverse environmental conditions , 2016, International journal of food sciences and nutrition.

[9]  L. Laghi,et al.  Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study , 2016, Scientific Reports.

[10]  S. Lebeer,et al.  Drying techniques of probiotic bacteria as an important step towards the development of novel pharmabiotics. , 2016, International journal of pharmaceutics.

[11]  B. Luppi,et al.  Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert. , 2016, Carbohydrate polymers.

[12]  B. Luppi,et al.  Mucoadhesive Buccal Tablets Based on Chitosan/Gelatin Microparticles for Delivery of Propranolol Hydrochloride. , 2015, Journal of pharmaceutical sciences.

[13]  L. Laghi,et al.  Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity , 2015, PloS one.

[14]  P. Mura,et al.  Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen. , 2015, International journal of pharmaceutics.

[15]  B. Luppi,et al.  Vaginal inserts based on chitosan and carboxymethylcellulose complexes for local delivery of chlorhexidine: preparation, characterization and antimicrobial activity. , 2015, International journal of pharmaceutics.

[16]  A. Gazzaniga,et al.  Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release. , 2014, Journal of pharmaceutical sciences.

[17]  S. Bornes,et al.  Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  P. Buffler,et al.  Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented , 2014, BMC Women's Health.

[19]  P. Teixeira,et al.  The role of lactobacilli and probiotics in maintaining vaginal health , 2014, Archives of Gynecology and Obstetrics.

[20]  S. Prakash,et al.  Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: in vitro preparation and characterization , 2013, Expert opinion on drug delivery.

[21]  G. Tzortzis,et al.  Microencapsulation of probiotics for gastrointestinal delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[22]  C. Wachihi,et al.  Selection, Phenotyping and Identification of Acid and Hydrogen Peroxide Producing Bacteria from Vaginal Samples of Canadian and East African Women , 2012, PloS one.

[23]  K. Senior.  Chlamydia: a much underestimated STI. , 2012, The Lancet. Infectious diseases.

[24]  E. S. Prudêncio,et al.  Microencapsulation of bifidobacteria by spray drying in the presence of prebiotics , 2012 .

[25]  R. Knight,et al.  Microbiota restoration: natural and supplemented recovery of human microbial communities , 2011, Nature Reviews Microbiology.

[26]  Zhongxiang Fang,et al.  Encapsulation of polyphenols – a review , 2010 .

[27]  P. Brigidi,et al.  Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  R. Holley,et al.  Stability of Lactobacillus reuteri in Different Types of Microcapsules , 2006 .

[29]  A. Sakr,et al.  Development and evaluation of extended release bioadhesive sodium fluoride tablets. , 2005, International journal of pharmaceutics.

[30]  M. F. Fernández,et al.  Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. , 2003, Journal of applied microbiology.

[31]  A. Bruce,et al.  Oral probiotics can resolve urogenital infections. , 2001, FEMS immunology and medical microbiology.

[32]  P. Brigidi,et al.  Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction. , 2000, Systematic and applied microbiology.